Repligen Corporation reported record revenue of $206.4 million for Q1 2022, a 45% increase year-over-year, with organic growth of 44%. The company's base business grew by 37%, while COVID-related sales accounted for 26% of revenue. Increased guidance for full year non-COVID business performance was provided.
Revenue reached a record $206.4 million, representing a 45% year-over-year increase as reported and 48% at constant currency.
Organic revenue growth was 44% for the quarter, with base business growth at 37%.
GAAP gross margin increased to 60.1%, and adjusted gross margin increased to 60.4%.
GAAP EPS increased to $0.81, while adjusted EPS increased to $0.92.
Repligen expects total revenue to be in the range of $770-$800 million. Base business revenue is expected to increase by 24%-31%. Overall revenue growth of 15%-19% is projected as reported.
Visualization of income flow from segment revenue to net income